Retatrutide is a synthetic peptide that acts as a triple agonist of the GLP-1, GIP, and glucagon (GCGR) receptors. It is primarily studied in metabolic research for its effects on glucose regulation, energy expenditure, and reduction of body fat mass through multi pathway signaling. It has also been examined for its role in appetite control and metabolic efficiency. For laboratory research only — not for human use.